The functional organization of polarized epithelia depends mostly on adhesion molecules belonging to the integrin and cadherin families. These molecules either recognize basement membrane components, such as laminins, or form intercellular junctions via homotypic interactions. Such tissue organization is often disrupted upon neoplastic transformation, and the resulting loss of functional polarization and cell cohesion might be a prerequisite for the invasive and metastatic behavior of carcinomas. Purpose: We studied modifications of thyroid adhesive mechanisms at various stages of neoplastic progression in terms of adhesion molecule expression, topography, and functional regulation by tyrosine kinases. Starting from this working hypothesis, we sought to identify one or more biological markers that would be suggestive of malignant transformation and poorer prognosis and that could be developed as a reliable indicator(s) in early diagnostic steps. Methods: The study was carried out on both surgical samples and the corresponding fine-needle aspiration biopsy smears (numbers of specimens collected: 19 adenomas, seven follicular carcinomas, 13 papillary carcinomas, and 39 normal tissues). Immunohistochemistry of tissue sections and smears and immunoprecipitation and western blot analysis of protein extracts were done with a battery of monoclonal and polyclonal antibodies. Northern blotting was performed on RNA extracts from frozen tissue samples and use of an integrin subunit P 4 complementary DNA probe.
Background:
The functional organization of polarized epithelia depends mostly on adhesion molecules belonging to the integrin and cadherin families. These molecules either recognize basement membrane components, such as laminins, or form intercellular junctions via homotypic interactions. Such tissue organization is often disrupted upon neoplastic transformation, and the resulting loss of functional polarization and cell cohesion might be a prerequisite for the invasive and metastatic behavior of carcinomas. Purpose: We studied modifications of thyroid adhesive mechanisms at various stages of neoplastic progression in terms of adhesion molecule expression, topography, and functional regulation by tyrosine kinases. Starting from this working hypothesis, we sought to identify one or more biological markers that would be suggestive of malignant transformation and poorer prognosis and that could be developed as a reliable indicator(s) in early diagnostic steps. Methods: The study was carried out on both surgical samples and the corresponding fine-needle aspiration biopsy smears (numbers of specimens collected: 19 adenomas, seven follicular carcinomas, 13 papillary carcinomas, and 39 normal tissues). Immunohistochemistry of tissue sections and smears and immunoprecipitation and western blot analysis of protein extracts were done with a battery of monoclonal and polyclonal antibodies. Northern blotting was performed on RNA extracts from frozen tissue samples and use of an integrin subunit P 4 complementary DNA probe.
Results: Our findings can be summarized as follows: 1) In normal thyroid cells, the cooperative role of integrin a^ and laminin 5/kalinin in hemidesmosome-mediated adhesion is missing, and recognition of the basal lamina occurs via integrin a 3 pi and laminin 1 and/or 2 (this pattern being maintained in adenomas but altered in carcinomas regardless of their histotype or differentiation grade); 2) only in carcinomas with clinical and/or histologic aggressiveness do neoexpression of integrin subunit (3 4 The induction and maintenance of a polarized and differentiated epithelial phenotype depend on expression, membrane sorting, and function of surface adhesion molecules (/) that provide domain-dependent mechanical and chemical information and are responsible for defining and maintaining cell topology and the functional polarity typical of epithelia. Such tissue organization is often disrupted upon neoplastic transformation, and the resulting loss of the polarized distribution and/or functional properties of adhesion molecules might be a prerequisite for the invasive and metastatic behavior of carcinomas (2,J).
Epithelial cells adhere to the basement membrane zone mostly via integrins (4) (5) (6) (7) . The major integrin restricted to the basal domain of the basal layer in squamous epithelia (8) (9) (10) (11) and in most columnar epithelia (J2J3) is 0^4, which usually codistributes with hemidesmosomes (14-16) and laminin 5/kalinin.
Epithelial cell-cell association is primarily mediated by E-cadherin (17) (18) (19) , a structural component of zonula adherens involved in forming homotypic bonds and in linking the microfilament network (20, 21 ) via a chain of cytoskeletal proteins termed "catenins" (22) (23) (24) .
Differentiated thyroid carcinomas originating from follicular cells are classified as a papillary type or a follicular type. Their poorly differentiated variants encompass the tall-cell carcinoma for papillary types (25) and insular (26) and Hiirthle cell (27) carcinomas for follicular types.
So far, no conclusive data have been provided about a simple and reliable method for correct, early diagnosis of thyroid tumors. Ideally, the preoperative differential diagnosis between benign and malignant thyroid neoplasms, performed on fine-needle aspiration biopsy smears, could be improved by two potential findings: 1) changes in integrin expression and topography and 2) aberrant synthesis, assembly, and/or adhesive status of the E-cadherin-catenin complex. Moreover, these modifications might provide a better prognostic definition of thyroid tumors. Accordingly, the aim of this study was to understand thyroid adhesive mechanisms during neoplastic progression in terms of adhesion molecule expression and functional regulation by tyrosine kinases. Starting from this working hypothesis, we sought to identify one or more biological markers suggestive of malignant transformation and poorer prognosis that would be suitable for development as reliable indicators in early diagnostic steps. The main morphologic-functional changes observed in thyroid cancers are pericellular redistribution of the integrin a 3 f3i complex, integrin a$ 4 neoexpression, and Ecadherin disorientation as well as a reduction in its tyrosine phoshorylation level.
Materials and Methods

Surgical Specimens
After clinical staging and fine-needle aspiration biopsies, fresh neoplastic thyroid tissue was surgically removed from patients previously treated with Lugol's iodine solution. All patients underwent thyroidectomy at San Luigi Gonzaga Hospital, Orbassano (Torino, Italy). The tumor tissue was either directly embedded in OCT 4583 (Miles Scientific, Naperville, IL) and snap-frozen for further immunohistochemical studies or directly frozen in liquid nitrogen for protein and RNA extraction. A portion of this tissue was used for routine histopathology. Tumor-free tissue was excised from each patient and processed in parallel. Frozen sections (5 UJTI) were serially cut in a Reichert-Jung cryomicrotome, transferred onto poly-L-lysinecoated slides, air-dried, and stored overnight at room temperature.
Histopathologic Classification
In parallel with immunohistochemistry, serial sections of each specimen were stained with hematoxylin-eosin to determine the histotype and subhistotype. We examined 19 surgical samples of follicular adenomas, seven of follicular carcinomas, and 13 of papillary carcinomas, hi addition, we examined a total of 39 normal tissue specimens. Of the seven follicular carcinomas examined, four were classified as poorly differentiated malignant neoplasms (HUrthle cell subtypes) and three as well-differentiated carcinomas; among the 13 papillary carcinomas, we observed five poorly differentiated variants (four tall-cell carcinomas and one sclerotic tumor), two follicular variants, five well-differentiated cancers, and one dedifferentiated carcinoma with wide anaplastic fields. The histologic features of each case, together with sex and age information, TNM staging (28), follow-up, and additional data are summarized in Table 1 .
Fine-Needle Aspiration Biopsies
The fine-needle aspiration biopsies were performed with a 22-gauge x 1.5-inch needle attached to a 30-mL plastic syringe (29) . After aspiration, the small fluid specimen was expelled from the needle and smeared onto a polylysine-coated slide. The smears were air-dried for 2 hours, pre-fixed in absolute methanol at -20 "C, and stored at -80 'C. We examined aspiration biopsy smears from 10 adenomas, five follicular carcinomas, and five papillary carcinomas. Written informed consent was obtained from each subject with the approval of the San Luigi Gonzaga Hospital review board.
Antibodies
The primary monoclonal antibodies (MAbs) used in this study (with the investigators who provided them) were as follows: MAR4 to integrin subunit P, and MAR6 (30) to integrin subunit a^ (from S. M6nard, Istituto Nazionale Tumori, Milano, Italy), GOH3 to integrin subunit a$ (from A. Sonnenberg, The Netherlands Cancer Institute, Amsterdam), F2 to integrin subunit ct 3 (from L. Zardi, Istituto Scientifico per lo Studio e la Cura dei Tumori, Genova, Italy), AA3 and S3-41 to integrin subunit P 4 (31) (from V. Quaranta, Scripps Research Institute, La Jolla, CA), IA9 to integrin subunit P 5 (from M. Hemler and R. Pasquahni, Dana-Farber Cancer Institute, Boston, MA), GB3 to laminin BM600/nicein (32) (from P. Verrando, Laboratoire.de Recherches Dermatologiques, Facultd de Meclecine, Nice, France), and 5H2 to laminin 2/merosin (33) (from E. Engvall, Wenrter Gren Institute, Stockholm, Sweden). Other MAbs were commercially obtained: SAM-1 to integrin subunit Oj and Gi9 to integrin subunit <x 2 (Immunotech, Marseille, France), LAM-89 to laminin 1 and PT-66 to phosphotyrosine-containing proteins (Sigma Chemical Co., St. Louis, MO), HECD-1 to human E-cadherin (Takara Shuzo Co., Kyoto, Japan), and MAbs to ot-catenin and P- T2aN0M0  T4aNlbM0  T3aN0M0  T2aN0M0  T2aN0M0  TlaNOMO  T4bN0M0  T2aNlaM0  T4bNlbM0  T4aNlbM0  T2bN0M0  T4aNlbM0  T4bN0M0  T2aN0M0  T2aN0M0  T1N0M0  T2aN0M0  T4aN0M+ (OTHfl  T2N0M0  T4N1M0 At recurrence (32) NED (31) NED (30) NED (29) NED (15) NED (27) NED (26) AWD (26) NED (25) NED (24) NED (24) NED (23) NED (40) NED (21) NED (13) NED (5) DOD (5) NED (2) NED (3) p4 expression *FC = follicular carcinoma; PC = papillary carcinoma. tDFC = differentiated follicular carcinoma; PDC = poorly differentiated carcinoma; DPC = differentiated papillary carcinoma; DDC = dedifferentiated carcinoma. t According to Hermanek and Sobin (28) . M+ = presence of metastases; PUL = pulmonary metastases; OTH = metastases in other organs. §NED = no evidence of disease; AWD = alive with disease; DOD = dead of disease. Months after surgical resection are indicated in parentheses. IIMediastinum.
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catenin (Affiniti, Nottingham, U.K.). Rabbit polyclonal antiserum R571O to integrin subunit f5 4 was provided by V. Quaranta; rabbit antiserum R1542 to integrin subunit (3, was a gift of L. 
Indirect Immunoperoxidase Technique
Experiments were performed as previously described (34) . Briefly, cryostat sections were fixed for 10 minutes in a chloroform-acetone mixture (1:1) at 4 'C, air-dried, and incubated for 10 minutes in phosphate-buffered saline (PBS) supplemented with 1 % serum from the same species as that for the secondary antibody. Serial sections were overlaid with 50 u.L of different antibodies in Tris-buffered saline (TBS) in 0.4% bovine serum albumin (BSA) and incubated at room temperature for 30 minutes in a moist chamber. After a thorough wash in PBS, the sections were incubated with the appropriate biotinylated secondary antibody and processed for the ABC method (avidin-biotin-peroxidase complex) using the Vectastain ABC Kit (Vector Laboratories, Inc., Burlingame, CA). After the sections were washed three more times, 100 uL of substrate was added for 5-10 minutes and was prepared as follows: 5 mg of 3-amino-9-ethylcarbazole (Sigma Chemical Co.) was dissolved in I mL of AVV-dimethylformamide (Merck, Darmstad, Federal Republic of Germany) supplemented with 9 mL of 100 nW sodium acetate (pH 5.2) and 100 uL of 12% H 2 O 2 . All samples were counterstained with Mayer's hemalum solution, mounted in Kaiser's glycerol gelatin (Merck), and examined with a Zeiss Axiophot photomicroscope (Zeiss, Jena, Federal Republic of Germany) equipped with 16x and 63x planapochromatic lenses.
Indirect Immunofluorescence Microscopy
Smears were fixed in a chloroform-acetone mixture (1:1) for 10 minutes at 4 "C and air-dried. After a 15-minute saturation with TBS-BSA (0.4% at 37 *C), the primary antibodies (MAbs AA3 and S3-41 to P 4 and MAR6 to o^) were layered onto slides and incubated in a moist chamber for 30 minutes. After rinsing in TBS containing 0.4% BSA, the slides were incubated with the appropriate rhodamine-tagged secondary antibody (Dakopatts, Copenhagen, Denmark) for 30 minutes at 37 "C. Coverslips were mounted in Mowiol 4-88 (Hoechst AG, Frankfurt/Main, Federal Republic of Germany).
Routine observations were carried out in a Zeiss Axiophot photomicroscope equipped for epifluorescence. Fluorescence images were recorded on Kodak T-Max 400 films exposed at 1000 ISO and developed in T-Max Developer for 10 minutes at 20 -C.
Detergent Solubilization
Surgical samples were directly snap-frozen in liquid nitrogen, pulverized in a B-Braun Mikro-Dismembrator (B-
sodium fluoride, 1 mM phenylmethyl sulfonyl fluoride, 2 Hg/mL leupeptin, and 2 ug/mL pepstatin A) by several passages in a Dounce homogenizer (PBI International, Milan, Italy) on ice. Tissue lysates and insoluble material were collected and centrifuged for 10 minutes at 20 000 rpm at 4 'C. Supematants were saved; in some experiments, detergent-insoluble pellets were resuspended in a buffer containing 50 mM Tris-HCl (pH 8.8) and 1% sodium dodecyl sulfate (SDS), sonicated, boiled for 5 minutes, and recentrifuged. SDS extracts were diluted 10-fold in extraction buffer, and supematants were adjusted to 0.1% SDS before immunoprecipitation.
Immunoprecipitation
Experiments were earned out as previously described (35) . Tissue extracts were adsorbed onto protein A-Sepharose CL-4B (Pharmacia LKB Biotechnology AB, Uppsala, Sweden) previously incubated with normal mouse serum (Sigma Chemical Co.). Precleared lysates were incubated with MAb HECD-1 to E-cadherin, and immunocomplexes were collected by protein A-Sepharose CL-4B coupled with rabbit anti-mouse immunoglobulin G (Pierce Chemical Co., Rockford, IL). After seven washes with extraction buffer, the final pellet was boiled in Laemmli buffer (36) in the presence of 4% (3-mercaptoethanol, and proteins were processed for SDS-polyacrylamide gel electrophoresis (PAGE) (8% polyacrylamide gels). For quantitative recovery of E-cadherin-catenin complexes, protein concentrations were normalized (BCA Protein Assay Reagent Kit; Pierce Chemical Co.), MAb HECD-1 was titrated in normal thyroid lysates, and saturating amounts of MAb were used in each immunoprecipitation experiment.
Western Blot Analysis
Frozen surgical samples were pulverized using a B-Braun Mikro-Dismembrator (37). For semiquantitative recovery of epithelium-specific components from the crude extract, each sample was divided into 200-mg pieces and processed in parallel for western blot analysis and for routine histology to evaluate the ratio of stromal contamination according to histotogic examination. The pulverized tissues were solubilized in boiling Laemmli buffer and sonicated; 300 |ig of presumptive epithelial proteins was loaded onto each lane. Alternatively, immunocomplexes, recovered from immunoprecipitation experiments after elution in boiling Laemmli buffer, were directly loaded onto gel lanes. Materials were fractionated by SDS-PAGE (8% polyacrylamide gels) under nonreducing conditions, and proteins were electrophoretically transferred to nitrocellulose filters (Hybond; Amersham Life Science. Inc.. Arlington Heights, IL) and analyzed as described previously (38) . Filters were probed with rabbit antiserum R1542 to integrin subunit (3|, R5710 to integrin subunit f5 4 , and MAbs to E-cadherin, a-catenin, pVcatenin, and phosphotyrosine-containing proteins. Specific binding was detected by the Enhanced Chemiluminescence System (Amersham Life Science, Inc.).
Northern Blot Analysis
Total RNA was isolated from pulverized, snapfrozen tissues by the acid guanidium method (39) using a Dounce homogenizer on ice, and northern blots were performed with 10 ug total RNA per lane. Ethidium bromide at a concentration of 0.2 Ug/mL was added before electrophoresis to 1% agarose gels containing formaldehyde to verify the integrity of the RNA by short-wavelength UV detection and to monitor the equivalence of loading before and after transfer to GeneScreen Plus filters (Du Pont NEN, Boston, MA) (i.e., the integrity and relative amounts of ribosomal RNAs were assessed). For additional RNA quantitation, filters were stained with 0.04% methylene blue in 0.5 M sodium acetate. The integnn subunit P 4 complementary DNA (cDNA) clone (1.5-kilobase [kb] £coRI fragment) was labeled with random priming (Megaprime DNA labeling system; Amersham Life Science, Inc.) and [
3 P]deoxycytidine triphosphate (3000 Ci/mmol; Amersham Life Science, Inc.). Membranes were pretreated and hybridized in 50% formamide (Merck) and 10% dextran sulfate (Sigma Chemical Co.) at 42 "C. Blots were washed twice with 2x sodium chloride-sodium citrate (SSC) at room temperature for 10 minutes, then twice with 2x SSC-1 % SDS at 60 # C for 30 minutes, and finally twice with O.lx SSC at room temperature for 30 minutes followed by exposure to autoradiography for 24 hours at -80 'C with intensifying screens.
Results
Expression and Regulation of Integrins and Laminins in Normal and Neoplastic Thyroid Tissues
In normal thyroid tissue, integrin chains a 3 and p, were exclusively exposed at the basal domain of follicular thyroid cells (Fig. la, panel A) , whereas <x 2 and Oj could not be detected (not shown). The a$4 complex was found to be absent in thyroid cells (Fig. le, panel  A) .
The basement membrane of normal thyroid tissue was composed of laminins 1 and 2 but not laminin 5 (not shown). The parallel lack of expression of both integrin Oep^ and laminin 5 at the basal aspect of thyroid cells strongly argues for the absence of hemidesmosomes in thyroid follicular cells. In fact, transmission electron microscopy as well as immunostaining with human sera reacting with hemidesmosome-specific bullous pemphigoid antigens revealed that thyroid cells do not assemble hemidesmosomes (not shown). The integrin subunits p 3 , P5, and (X, did not show any obvious immunoreactivity.
The above distribution pattern was totally retained in follicular adenomas (Fig. Fig. 1 . Adhesion molecule expression and topography in normal and neoplastic thyroid tissues. Panel A: hi normal (a) and adenomatous (b) thyroid tissues, the integrin subunit 03 is exposed at the basal domain of thyroid cells, whereas it is aspecifically redistributed along the cell margins in follicular (c) and papillary (d) carcinomas. The p4 integrin chain is not present in normal (e) and adenomatous (f) follicular cells, but it is strongly expressed in poorly differentiated and/or clinically aggressive follicular (g, case FCl) and papillary (h, case PC 13) carcinomas. The integrui subunit a* expression entirely matches that of p4 (not shown). Bar denotes 16 um. Panel B: hi normal thyroid tissue (a) and in adenoma tissue (not shown), E-cadherin is selectively enriched at cell-cell contacts, hi malignant tumors (b), the molecule is conserved but pericellularly redistributed. The expression of P-catenin entirely matches that of E-cadherin (not shown). Bar denotes 16 |im and, for both insets, 4 |im. lb and f, panel A) but was subverted in both papillary and follicular carcinomas (Fig. lc, d, g, and h, panel A) .
To support immunohistochemical data and to check the molecular mass of the integrin subunit Pi, we performed immunoblot analysis on some normal tissue and tumor samples. A Pi polyclonal antiserum identified a 110-kd band present at similar intensity levels (Fig. 2, panel  A) .
Surprisingly, we observed neoexpression of the integrin 0^4 heterodimer in 11 of 20 malignant tumors (Fig. lg and h , panel A; Table 1 ). More precisely, two of three well-differentiated follicular carcinomas and nine of 13 poorly differentiated and/or clinically aggressive cancers were found to be p 4 and 0$ positive. Expression of the P 4 chain in these specific tumors was confirmed both by immunofluorescence in fine-needle aspiration biopsy smears (Fig. 2, panel B) and by western blot analysis (Fig. 2, panel C) . Northern blot analysis revealed a specific 5.5-kb P 4 transcript with variable band intensity in those carcinomas that were found to express p 4 protein in immunohistochemistry and western blot experiments (Fig. 2, panel D) . Thus, the data indicate that, in some thyroid cancers, a transcriptionally regulated expression of P 4 occurs, which leads to a^ membrane exposure.
As with normal thyroid tissue, we did not observe any P3 or p 5 immunoreactivity in thyroid cancers (not shown).
Among basal lamina components, laminin 1 retained the normal pattern within rumors, whereas laminin 5 remained undetectable in carcinomas (not shown). Interestingly, laminin 2 was detected at high levels in integrin subunit P 4 -negative tumors, but it was totally absent in integrin subunit p 4 -positive cancers (not shown). The inverse relationship between integrin 0^4 and laminin 2 immunoreactivity was strikingly replicable: All carcinomas showing integrin subunit P 4 neosynthesis did not express laminin 2.
Expression and Functional Status of the E-cadherin-Catenin Complex in Normal and Neoplastic Thyroid Tissues E-cadherin was detected in thyroid follicular epithelium at the boundaries between adjacent cells (Fig. la, panel B) . This strictly lateral topography was maintained in adenomas; however, it was critically subverted in malignant tumors, where E-cadherin was diffusely distributed over the entire membrane in all neoplastic cells (Fig. lb, panel B) . The distribution of (J-catenin was identical to that of E-cadherin in normal, adenomatous, and cancerous thyroid tissues (not shown).
E-cadherin protein levels following SDS extraction were identical in normal, adenomatous, and cancerous thyroid tissues. Quantitative recovery of a-and p-catenins after non-ionic detergent extraction was also identical in all samples (Fig. 3, panel A) .
The loss of lateral exposure and the pericellular distribution of E-cadherin indicate that the association of E-cadherin with the cytoskeleton could be impaired in malignant thyroid rumors. To verify that this is actually the case, we measured the relative fractions of total E-cadherin that either were or were not resistant to extraction by non-ionic detergents (Fig. 3,  panel B) . In fact, in normal thyroid tissues and in thyroid adenomas, E-cadherin was only partially extractable in nonionic detergents, with approximately 50% of the total pool being recovered from the cytoskeleton-associated fraction; conversely, in malignant tumors, most E-cadherin could be extracted by non-ionic detergents, and the insoluble fraction represented only a minor portion. These results support morphologic data and indicate that the complex is disconnected from the microfilament network and undergoes pericellular relocalization only in carcinomas.
Finally, we examined the tyrosinephosphorylation status of the E-cadherincatenin complex in detergent extracts from normal and neoplastic thyroid tissues (Fig. 3, panel Q . In E-cadherin immunoprecipitates, three bands of 130, 100, and 88 kd, respectively, comigrating western blot analysis of the E-cadherin-catenin complex in normal and neoplastic thyroid tissues. The complex is expressed at comparable levels, with a conserved stoichiometry, in extracts from both benign and malignant specimens. Panel B: detergent resistance of E-cadherin in normal and neoplastic thyroid tissues. In normal thyroid tissues and adenomas, E-cadherin is largely resistant to Triton X-100 extraction; in contrast, in carcinomas, it is readily extracted by non-ionic detergents. Panel C: tyrosine-phosphorylation status of the E-cadherin-catenin complex in normal and neoplastic thyroid tissues. In normal thyroid tissues and adenomas, three bands, comigrating with Ecadherin, a-catenin, and fJ-catenin, can be observed. In contrast, no tyrosine phosphorylation of E-cadherin is detectable in follicular and papillary carcinomas. IP = immunoprecipitation; WB = western blot; NT = normal thyroid tissue; FA = follicular adenoma; FC = follicular carcinoma; PC = papillary carcinoma; Sol. = Triton X-100 soluble; Ins. = Triton X-100 insoluble. Molecular mass markers are indicated on the left in kilodaltons.
with E-cadherin, a-catenin, and P-catenin, were identified by western blot analysis using a phosphotyrosine-specific antibody.
No tyrosine phosphorylation of y-catenin-plakoglobin was observed. One striking observation was that the level of tyrosine phosphorylation of E-cadherin was markedly decreased and almost abolished in thyroid carcinomas; this finding was consistently observed in all malignant neoplasms, and it was always associated with unmodified E-cadherin protein expression.
Discussion
The epithelial phenotype is characterized by the following two discrete membrane domains involved in tissue polarization and cell cohesion: the basal domain and the lateral domain. The basal domain is responsible for recognition of matrix ligands and attachment to the basement membrane zone by means of specific receptors. One major basal receptor is the integrin 0^4 heterodimer that is also responsible for hemidesmosome assembly (14) (15) (16) . The lateral domain mediates epithelial cell alignment by means of junction-associated adhesion molecules, e.g., cadherins (40, 41) and integrins of the p^ subfamily (4) (5) (6) .
Spatial disorganization of, functional impairment of, or quantitative alterations in the levels of several adhesion molecules have been widely reported in epithelial tumors [for references, see
Q J,42)1
The aim of our study was to investigate the adhesive mechanisms involved in es-tablishing the polarized phenotype of thyroid cells and to observe the topographic and functional modifications of two classes of relevant adhesion molecules at various stages of neoplastic progression. In our working hypothesis, alterations of cellular adhesiveness occurring upon malignant transformation would result in a rearrangement of adhesion molecule expression and function that could be readily detected in preoperative fine-needle aspiration biopsy smears as well as in surgical samples.
The fact that the thyroid carcinomas that switch on P 4 expression and switch off laminin 2 synthesis are those that are associated with the most aggressive behavior could be of major importance both from a biological viewpoint and from a clinical viewpoint. The role of integrin subunit p 4 is not yet fully understood. The 0^4 heterodimer has been shown to mediate stable adhesion to laminin 1, laminin 2, and laminin 5 (43-45) . In contrast, integrin subunit o^-transfected cells can adhere to laminin 2, but they fail to attach to and spread on laminin 1 (46) . Therefore, the fact that normal thyroid tissue expresses one integrin receptor ((X3P1) and two laminin isoforms (laminins 1 and 2) and yet only one ligand is recognized by the integrin heterodimer seems paradoxical. We suggest that, under normal conditions in vivo, recognition between follicular cells and the basal lamina is mediated by the interaction of integrin (X3P1 and laminin 2 (and possibly by unknown integrins or nonintegrin receptors). When synthesis of laminin 2, which has been shown to be related to a highly differentiated phenotype (33, 47) , is switched off in a subset of aggressive thyroid tumors, the de novo expression of 0^4 might confer a selective advantage for invasion by providing a complementary and more versatile laminin receptor capable of triggering recognition events and attachment to laminin 1 that precede infiltration.
Detection of 0^4 exposure can be achieved easily in smears from fineneedle aspiration biopsies. If validated by a large-scale clinical investigation that is now in progress (Orlandi F, Saggiorato E, Serini G, Trusolino L, Marchisio PC, Angeli A: manuscript in preparation), this finding might be relevant for the presurgical detection of aggressive carcinomas and for the differential diagnosis between follicular adenomas and carcinomas.
E-cadherin-p-catenin localization in normal and adenomatous thyroid tissues is restricted to the lateral domain of juxtaposed thyroid cells. In contrast, in carcinomas, the complex undergoes pericellular diffusion. This subverted topography is accompanied by a different pattern of detergent extractability between noncancerous and cancerous lesions that is consistent with disconnection of the Ecadherin-catenin complex from the actin microfilaments. This surface rearrangement is not associated with any changed synthesis of E-cadherin and a-and Pcatenins. To our knowledge, this is the first report in which loss of E-cadherincatenin lateral polarization and removal of the complex from cytoskeleton-associated adhesion sites, without reduced expression of the molecules involved, have been described in the progression from benign to malignant lesions.
Tyrosine phosphorylation of the E-cadherin-catenin complex plays a key role in perturbation of the cadherin cell adhesion system (3, 48, 49) . In normal adult tissues, specific proto-oncogenic tyrosine kinases of the src family are enriched at zonula adherens, where the level of tyrosine phosphorylation is high (50) . Since a positive association exists in our data between the three parameters of decreased tyrosine phosphorylation, loss of detergent insolubility, and pericellular redistribution of E-cadherin, we suggest that tyrosine phosphorylation of the Ecadherin cytodomain may play a role in controlling not only the structure of the whole molecule and, hence, intercellular adhesion, but also its stability within the membrane plane. In addition, dissociation of the E-cadherin-catenin complex from junctional regions could drive the complex away from kinases (57) and phosphatases (52) specifically acting on E-cadherin and responsible for the phosphorylation status of the molecule under normal conditions. In summary, the addition of a panel of MAbs to adhesion molecules in the toolbox of thyroid surgical pathologists, if validated in larger studies, may expand the options to reach a reasonably correct early diagnosis and even gain some prognostic information from routine needle biopsies.
